Hermans K, Van Den Plas D, Kerimova S, Carleer R, Adriaensens P, Weyenberg W, et al
The 8 Finding That Should Settle the Question In a 2025 cross-sectional study published in Obesity Medicine , researchers tracked who was prescribing GLP-1 medications and how long their patients stuck with the treatment
patients who experience signs or symptoms suggestive of angina following its administration should, therefore, be evaluated for the presence of CAD or a predisposition to variant angina before receiving additional doses
When it comes to using semaglutide in people with high cortisol levels, doctors need to consider several factors
A GLP-1 agonist administered during this window helps counteract the cortisol-driven glucose rise, potentially offering tighter glycemic control through the most metabolically active part of your day